Bridgeway Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

Bridgeway Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$144K	Hold	194,800	–	–	﹤0.01%	1108
2026 Q1	$135K	Hold	194,800	–	–	﹤0.01%	1091
2025 Q4	$139K	Buy	194,800 +175,000	+884%	+$238K	﹤0.01%	1080
2025 Q3	$32.1K	Hold	19,800	–	–	﹤0.01%	1180
2025 Q2	$12.1K	Hold	19,800	–	–	﹤0.01%	1173
2025 Q1	$11.3K	Sell	19,800 -208,600	-91%	-$206K	﹤0.01%	1167
2024 Q4	$327K	Sell	228,400 -7,100	-3%	-$15.9K	0.01%	904
2024 Q3	$455K	Buy	235,500 +67,500	+40%	+$191K	0.01%	886
2024 Q2	$521K	Sell	168,000 -25,000	-13%	-$103K	0.01%	849
2024 Q1	$1.01M	Hold	193,000	–	–	0.02%	740
2023 Q4	$625K	Buy	193,000 +11,100	+6%	+$24K	0.01%	887
2023 Q3	$464K	Hold	181,900	–	–	0.01%	897
2023 Q2	$1.07M	Hold	181,900	–	–	0.03%	714
2023 Q1	$518K	Buy	181,900 +79,600	+78%	+$224K	0.01%	877
2022 Q4	$206K	Buy	+102,300	New	+$250K	0.01%	1079

Other funds holding TNYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bridgeway Capital Management's TNYA Position: Q2 2026 in Review

Bridgeway Capital Management held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 194,800 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Bridgeway Capital Management first reported a position in TNYA in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.07M in Q2 2023. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Bridgeway Capital Management held 194,800 shares of Tenaya Therapeutics worth $144K as of Q2 2026.
Bridgeway Capital Management left its Tenaya Therapeutics share count unchanged in Q2 2026.
Tenaya Therapeutics made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1108 holding.
Bridgeway Capital Management first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 15 quarters since.
Bridgeway Capital Management's Tenaya Therapeutics position peaked at $1.07M in Q2 2023.
101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.